Answers are grounded in this paper and cite their sources.
Diabetic Nephropathy (DN) affects over half of the diabetic population, is a significant global health concern and a leading cause of end-stage renal disease (ESRD). Recent studies emphasised the potential of herbal medicinal plants, particularly those with antioxidant properties and anti-inflammatory properties, in treating DN. This research examines the active phytochemicals and molecular mechanisms of D5 chooranam in the treatment of DN. Data on these phytochemicals were sourced from the IMPPAT database. Sixteen compounds were selected for further analysis based on ADMET profiling criteria. Target prediction analysis was performed for the selected phytochemicals. Disease-associated targets were identified using multiple databases, and comparison of the phytochemical and disease target datasets revealed 462 overlapping targets. Functional analysis revealed enrichment in pathways related to insulin resistance, PI3K-AKT signaling, and AGE-RAGE metabolism. Hub targets were identified using degree measures, with the top 10 genes selected for further analysis. The compound kaempferol showed strong interactions with genes such as TP53 , MAPK1 , MAPK3 , AKT1 , and SRC . Molecular docking and 500 ns molecular dynamics simulation studies of these five complexes showed that the SRC–kaempferol complex exhibited stable interactions, structural stability throughout the simulation period, and favorable binding energies. This study elucidates the pharmacologically active compounds in D5 chooranam by combining traditional knowledge with modern scientific insights using network pharmacology, thereby informing treatment strategies.
No takes yet. Share an insight, caveat, or question.
Loganathan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: